TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
LBRX

LB Pharmaceuticals Inc

Healthcare · Biotechnology

37.00$ -0.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LBRX
Line item Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
100.0% – – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.9% – – 86.1% 76.8% 76.8% 98.6% 98.6% 98.9% 98.2%
23.7% – – 68.5% 73.9% 73.9% 84.1% 79.9% 81.5% 78.3%
97.1% – – – 73.9% 73.9% 98.0% 94.3% 92.9% 90.6%
167.9% – – 382.0% 46.0% 639.7% 3.3% 3.7% 3.8% 8.1%
11.7% – – 24.2% 20.3% 20.3% 2.1% 2.4% 2.8% 6.5%
– – – – 3.8% 3.8% 0.2% 0.2% 0.2% 0.2%
1.8% – – 6.9% 3.3% 3.3% 0.8% 0.7% 1.8% 1.0%
-67.9% – – -282.0% 54.0% -539.7% 96.7% 96.3% 96.2% 91.9%
-77.3% – – -311.1% -594.9% -594.9% -36.8% -41.4% -37.8% -55.3%
4.8% – – 66.9% 1.3% 1.3% 7.9% 8.1% 7.2% 8.3%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?